1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Menicon Co Ltd

Menicon Co Ltd

MECNY
Menicon Co LtdUS flagOther OTC
88.63
USD
- -
- -
26.87BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
237.89
241.42
236.56
254.09
272.95
287.33
292.02
285.45
331.2
363.14
381.82
400.02
190.65
Basic EPS, GAAP
3.87
5.47
7.81
8.97
9.46
12.7
14.03
19.71
21.43
24.31
14.91
18.51
4
Free Cash Flow per Basic Share
-12.44
2.55
12.72
5.15
10.85
6.47
7.72
-4.13
-10.67
-0.74
-31.11
-11.67
- -
Dividend per Share
1.56
1.88
1.72
1.94
2.37
3.12
3.41
3.49
4.37
5.01
6.25
6.27
- -
Book Value per Share
123.53
127.13
128.37
135.74
143.88
152.97
166.4
175.74
190.99
209.64
217.82
230.53
223.31
Tangible Book Value per Share
86.13
94.26
106.73
102.12
116.31
128.97
160.51
160.11
183.31
208.25
230.47
233.32
235.63
Basic Weighted Avg Shares
262
262
285
284
281
282
289
302
302
303
304
304
305
Sales/Revenue/Turnover
62,209
63,131
67,332
72,052
76,672
80,898
84,519
86,209
100,172
110,194
116,192
121,491
58,066
Operating Margin (%)
3.69
4.54
5.14
5.43
5.73
6.89
8.32
9.4
9.94
10.95
7.7
8.27
6.37
Depreciation Expense
3,774
4,198
4,365
4,653
5,007
4,640
5,421
6,028
7,293
7,448
7,947
8,450
- -
Net Income, GAAP
1,011
1,431
2,224
2,543
2,657
3,576
4,060
5,952
6,481
7,377
4,538
5,621
1,217
Effective Tax Rate (%)
61.33
50.01
43.28
38.18
38.13
37.49
35.13
28.73
34.53
35.93
36.16
39.68
41.45
Profit Margin (%)
1.63
2.27
3.3
3.53
3.47
4.42
4.8
6.9
6.47
6.69
3.91
4.63
2.1
Working Capital
11,231
11,026
15,136
16,493
19,392
24,016
19,971
47,677
41,500
53,349
35,718
56,177
33,613
LT Debt
15,609
15,669
11,918
15,433
10,590
15,060
9,368
40,338
37,636
49,938
44,579
71,856
46,615
Total Equity
33,149
33,873
38,440
37,678
40,120
42,548
53,519
60,981
67,042
74,663
81,802
86,151
85,918
Return on Invested Capital (%)
- -
2.65
3.54
4.23
4.7
5.78
6.95
6.55
5.95
6.42
4.03
3.83
1.38
Return on Capital (%)
- -
3.09
4.57
4.82
4.83
6.21
6.76
7.64
6.74
6.99
3.85
4.28
1
Return on Common Equity (%)
- -
4.37
6.37
6.78
6.73
8.57
8.9
11.76
11.69
12.16
6.99
8.25
1.83

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
26,214
- -
26,076
LT Borrowings
40,584
- -
41,093
LT Finance Leases
3,995
- -
5,522
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
76
- -
76
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
85,771
- -
80,936
Cash, Cash Equivalents & STI
46,911
- -
40,465
Accounts Receivable, Net
13,340
- -
14,093
Inventories
18,802
- -
20,318
Total Current Liabilities
50,053
- -
47,323
Payables & Accruals
- -
- -
- -
ST Debt
26,214
- -
26,076
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.99%
10.03%
5.32%
Free Cash Flow
441.14%
787.36%
-62.57%
Net Income, GAAP
17.7%
10.94%
23.87%
Sales/Revenue/Turnover
6.83%
7.64%
4.56%
Total Cash Common Dividend
- -
14.5%
0.16%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
28,446
29,680
29,275
28,791
116,192
2025
- -
- -
- -
- -
121,491
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5.19
- -
- -
- -
14.91
2025
- -
- -
- -
- -
18.51
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
6.25
2025
- -
- -
- -
- -
6.27
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Koji Kawaura
Full Time Employees
4,325
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
3-21-19, Aoi, Naka-ku Nagoya United States of America 460-0006
IPO Date
Oct 1, 2021
Website
menicon.co.jp
Similar Companies
S2Medical AB (publ) (S2M.ST)
AddLife AB (publ) (ALIF-B.ST)
Earum Pharmaceuticals Limited (EARUM.BO)
Careplus Group Berhad (0163.KL)
Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)
The Cooper Companies, Inc. (COO)
Business
Menicon Co Ltd Menicon Co., Ltd. manufactures and sells contact lenses, lens care products, and related ophthalmic solutions worldwide, operating as Japan's first and largest contact lens maker with a comprehensive focus on material development, lens design, manufacturing, and care solutions; its core offerings include soft contact lenses such as 2WEEK Menicon Rei and Menicon EX, specialty lenses including orthokeratology and intraocular lenses (IOLs) like Menicon O2-32 and colored IOLs, myopia management solutions for children and youth, daily disposable lenses, pharmaceuticals comprising eye drops and cleaning solutions, and medical devices alongside healthcare and life care services through subsidiaries like Menicon Life Science and Menicon Nect. Founded in 1951 by Kyoichi Tanaka and headquartered at 3-21-19 Aoi, Naka-ku, Nagoya, Japan, the company serves hospitals, eye clinics, optical shops, and pharmaceutical wholesalers in Japan while exporting to over 80 countries across Asia, Europe, the Americas, and other regions, with key production facilities in Singapore, Malaysia, the Netherlands, and Gifu Prefecture, Japan. Recent strategic expansions include the September 2024 acquisition of 100% shares in three Oculus Pte Ltd distributors—Oculus Visioncare (Singapore), Oculus (Malaysia), and others in Southeast Asia—to establish robust sales networks for brands like FreshKon colored lenses amid growing regional demand; ongoing investments in its largest overseas plant in Kulim, Malaysia, valued at up to 50 billion yen and slated for daily disposable lens production starting in late 2025 or 2026 with sustainable features like solar panels; and enhanced R&D efforts dedicating about 10% of revenue to innovations, supporting 7.5% revenue growth to ¥134.6 billion in fiscal 2024 alongside 15% international sales increases through partnerships and market share gains in orthokeratology and lens care in China and Asia.